Showing 361 - 380 results of 922 for search 'Grade 22', query time: 0.08s Refine Results
  1. 361

    The Safety and Efficacy of the Repeated PRRT with [90Y]Y/[177Lu]Lu-DOTATATE in Patients with NET by Anna Zemczak, Paweł Gut, Dariusz Pawlak, Maciej Kołodziej, Leszek Królicki, Beata Kos-Kudła, Marek Ruchała, Grzegorz Kamiński, Jolanta Kunikowska

    Published 2021-01-01
    “…The median cumulative administered activity was 22.2 GBq (the range: 17.8–30.7 GBq). Myelodysplastic syndrome occurred in one patient (3.8%), and grade 4 renal toxicity was also detected in one patient (3.8%). …”
    Get full text
    Article
  2. 362
  3. 363

    Preliminary study on the diagnostic value of urine cell glucose metabolism detection for male urothelial carcinoma by Yaoyao Wu, Angchao Ye, Zhenguo Bu, Shaoxing Zhu, He Wang, Yipeng Xu

    Published 2024-12-01
    “…“Glucose metabolism 2” had a sensitivity of 86.21% for low-grade urothelial carcinoma, while “Urine Exfoliative 4” had a sensitivity of 58.62%. …”
    Get full text
    Article
  4. 364

    Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with potentially resectable stage IIIA/IIIB NSCLC: a retrospective study by Yuchen Wang, Xiaobo Ma, Kewei Ma, Xi Chen, Hua He, Xiangye Zhao, Mengge Fan, Yinghui Xu

    Published 2025-01-01
    “…The percentage of patients with pathologic complete response was 36.4% (16/44, 95% CI: 22.8%–52.3%) after NCI compared with 8.3% (2/24, 95% CI: 1.5%–28.5%) after NC (P = 0.012). …”
    Get full text
    Article
  5. 365
  6. 366
  7. 367

    Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherap... by Weiming Liang, Weiming Liang, Zhijing Wang, Zhilong Huang, Yanping Huang, Chunyan Li, Yiwen Liang, Miaoyan Huang, Duo Zhang, Chenchen Li

    Published 2025-02-01
    “…The CR, PR, SD, PD, ORR, DCR, and grade ≥ 3 trAEs rate were 0.06 [95% confidence interval (CI), 0.04 to 0.07], 0.22 (95% CI, 0.16 to 0.30), 0.27 (95% CI, 0.23 to 0.31), 0.31 (95% CI, 0.20 to 0.44), 0.28 (95% CI, 0.21 to 0.37), 0.57 (95% CI, 0.47 to 0.67) and 0.26 (95% CI, 0.14 to 0.40), respectively. …”
    Get full text
    Article
  8. 368
  9. 369

    Effectiveness of Flexible Ureterorenoscopy and Laser Lithotripsy for Multiple Unilateral Intrarenal Stones Smaller Than 2 cm by Erdal Alkan, Oguz Ozkanli, Egemen Avci, Mirac Turan, M. Murad Başar, Oguz Acar, M. Derya Balbay

    Published 2014-01-01
    “…Mean age, mean number of stones per patient, mean stone burden, and mean operative time were 40.2±10.9 years (23–63), 3.6±3.0 (2–18), 22.2±8.4 mm (12–45), and 60.3±22.0 minutes (30–130), respectively. …”
    Get full text
    Article
  10. 370

    The Impact of Locoregional Therapy in Nonmetastatic Inflammatory Breast Cancer: A Population-Based Study by Mahvish Muzaffar, Helen M. Johnson, Nasreen A. Vohra, Darla Liles, Jan H. Wong

    Published 2018-01-01
    “…Multivariate analysis showed that black race HR (1.22, 95% CI 1.18–1.35), ER negative status (HR 1.22, 95% CI 1.16–1.28), and higher grade (HR 1.14, 95% CI 1.07–1.20) were associated with poor outcome. …”
    Get full text
    Article
  11. 371

    Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management by Anna J. Lomax, Jennifer Lim, Robert Cheng, Arianne Sweeting, Patricia Lowe, Neil McGill, Nicholas Shackel, Elizabeth L. Chua, Catriona McNeil

    Published 2018-01-01
    “…A bullous pemphigoid-like skin reaction with refractory pruritus responded to corticosteroids and neuropathic analgesia. Disabling grade 3-4 oligoarthritis required sulfasalazine therapy in combination with steroids. …”
    Get full text
    Article
  12. 372

    Prognostic Significance of DNA Cytometry in Carcinoma of the Uterine Cervix FIGO Stage IB and II by Hans Jürgen Grote, Nicolaus Friedrichs, Natalia Pomjanski, Helen Friderike Guhde, Olaf Reich, Alfred Böcking

    Published 2001-01-01
    “…DNA stemline ploidy, DNA stemline aneuploidy, 5c exceeding rate, 9c exceeding rate, 2c deviation index, and DNA malignancy grade were computed. DNA‐variables as well as various clinical and histological variables were related to survival rates. …”
    Get full text
    Article
  13. 373

    Safety and Efficacy of Everolimus Plus Exemestane in Postmenopausal Women with Treatment-refractory Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Adv... by Yuan-Ching Chang, Kun-Ming Rau, Dar-Ren Chen, Tsu-Yi Chao, Ming-Feng Hou, Chiun-Sheng Huang*

    Published 2023-07-01
    “…Taiwanese patients (n = 22) had similar baseline characteristics compared with BOLERO-2 cohort; most (17/22) had discontinued due to disease progression. …”
    Get full text
    Article
  14. 374
  15. 375
  16. 376
  17. 377
  18. 378
  19. 379
  20. 380